The global market for Leflunomide is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Leflunomide market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Leflunomide market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Leflunomide market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Leflunomide market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Leflunomide players cover Sanofi, DM Pharma and Changzhou Yabang Pharmaceutical. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Leflunomide market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Leflunomide market, with both quantitative and qualitative data, to help readers understand how the Leflunomide market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Leflunomide market and forecasts the market size by Type (99% Purity and 99.5% Purity,), by Application (Rheumatoid Arthritis and Other.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
99% Purity
99.5% Purity
Segmentation by application
Rheumatoid Arthritis
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sanofi
DM Pharma
Changzhou Yabang Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Leflunomide, Research Methodology, etc.
Chapter 2: Executive Summary, global Leflunomide market size (sales and revenue) and CAGR, Leflunomide market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Leflunomide sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Leflunomide sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Leflunomide market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi, DM Pharma and Changzhou Yabang Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Leflunomide Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Leflunomide by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Leflunomide by Country/Region, 2017, 2022 & 2028
2.2 Leflunomide Segment by Type
2.2.1 99% Purity
2.2.2 99.5% Purity
2.3 Leflunomide Sales by Type
2.3.1 Global Leflunomide Sales Market Share by Type (2017-2022)
2.3.2 Global Leflunomide Revenue and Market Share by Type (2017-2022)
2.3.3 Global Leflunomide Sale Price by Type (2017-2022)
2.4 Leflunomide Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Other
2.5 Leflunomide Sales by Application
2.5.1 Global Leflunomide Sale Market Share by Application (2017-2022)
2.5.2 Global Leflunomide Revenue and Market Share by Application (2017-2022)
2.5.3 Global Leflunomide Sale Price by Application (2017-2022)
3 Global Leflunomide by Company
3.1 Global Leflunomide Breakdown Data by Company
3.1.1 Global Leflunomide Annual Sales by Company (2020-2022)
3.1.2 Global Leflunomide Sales Market Share by Company (2020-2022)
3.2 Global Leflunomide Annual Revenue by Company (2020-2022)
3.2.1 Global Leflunomide Revenue by Company (2020-2022)
3.2.2 Global Leflunomide Revenue Market Share by Company (2020-2022)
3.3 Global Leflunomide Sale Price by Company
3.4 Key Manufacturers Leflunomide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Leflunomide Product Location Distribution
3.4.2 Players Leflunomide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Leflunomide by Geographic Region
4.1 World Historic Leflunomide Market Size by Geographic Region (2017-2022)
4.1.1 Global Leflunomide Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Leflunomide Annual Revenue by Geographic Region
4.2 World Historic Leflunomide Market Size by Country/Region (2017-2022)
4.2.1 Global Leflunomide Annual Sales by Country/Region (2017-2022)
4.2.2 Global Leflunomide Annual Revenue by Country/Region
4.3 Americas Leflunomide Sales Growth
4.4 APAC Leflunomide Sales Growth
4.5 Europe Leflunomide Sales Growth
4.6 Middle East & Africa Leflunomide Sales Growth
5 Americas
5.1 Americas Leflunomide Sales by Country
5.1.1 Americas Leflunomide Sales by Country (2017-2022)
5.1.2 Americas Leflunomide Revenue by Country (2017-2022)
5.2 Americas Leflunomide Sales by Type
5.3 Americas Leflunomide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leflunomide Sales by Region
6.1.1 APAC Leflunomide Sales by Region (2017-2022)
6.1.2 APAC Leflunomide Revenue by Region (2017-2022)
6.2 APAC Leflunomide Sales by Type
6.3 APAC Leflunomide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Leflunomide by Country
7.1.1 Europe Leflunomide Sales by Country (2017-2022)
7.1.2 Europe Leflunomide Revenue by Country (2017-2022)
7.2 Europe Leflunomide Sales by Type
7.3 Europe Leflunomide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Leflunomide by Country
8.1.1 Middle East & Africa Leflunomide Sales by Country (2017-2022)
8.1.2 Middle East & Africa Leflunomide Revenue by Country (2017-2022)
8.2 Middle East & Africa Leflunomide Sales by Type
8.3 Middle East & Africa Leflunomide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Leflunomide
10.3 Manufacturing Process Analysis of Leflunomide
10.4 Industry Chain Structure of Leflunomide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Leflunomide Distributors
11.3 Leflunomide Customer
12 World Forecast Review for Leflunomide by Geographic Region
12.1 Global Leflunomide Market Size Forecast by Region
12.1.1 Global Leflunomide Forecast by Region (2023-2028)
12.1.2 Global Leflunomide Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Leflunomide Forecast by Type
12.7 Global Leflunomide Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Leflunomide Product Offered
13.1.3 Sanofi Leflunomide Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 DM Pharma
13.2.1 DM Pharma Company Information
13.2.2 DM Pharma Leflunomide Product Offered
13.2.3 DM Pharma Leflunomide Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 DM Pharma Main Business Overview
13.2.5 DM Pharma Latest Developments
13.3 Changzhou Yabang Pharmaceutical
13.3.1 Changzhou Yabang Pharmaceutical Company Information
13.3.2 Changzhou Yabang Pharmaceutical Leflunomide Product Offered
13.3.3 Changzhou Yabang Pharmaceutical Leflunomide Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Changzhou Yabang Pharmaceutical Main Business Overview
13.3.5 Changzhou Yabang Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Leflunomide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Leflunomide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 99% Purity
Table 4. Major Players of 99.5% Purity
Table 5. Global Leflunomide Sales by Type (2017-2022) & (Tons)
Table 6. Global Leflunomide Sales Market Share by Type (2017-2022)
Table 7. Global Leflunomide Revenue by Type (2017-2022) & ($ million)
Table 8. Global Leflunomide Revenue Market Share by Type (2017-2022)
Table 9. Global Leflunomide Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Leflunomide Sales by Application (2017-2022) & (Tons)
Table 11. Global Leflunomide Sales Market Share by Application (2017-2022)
Table 12. Global Leflunomide Revenue by Application (2017-2022)
Table 13. Global Leflunomide Revenue Market Share by Application (2017-2022)
Table 14. Global Leflunomide Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Leflunomide Sales by Company (2020-2022) & (Tons)
Table 16. Global Leflunomide Sales Market Share by Company (2020-2022)
Table 17. Global Leflunomide Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Leflunomide Revenue Market Share by Company (2020-2022)
Table 19. Global Leflunomide Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Leflunomide Producing Area Distribution and Sales Area
Table 21. Players Leflunomide Products Offered
Table 22. Leflunomide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Leflunomide Sales by Geographic Region (2017-2022) & (Tons)
Table 26. Global Leflunomide Sales Market Share Geographic Region (2017-2022)
Table 27. Global Leflunomide Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Leflunomide Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Leflunomide Sales by Country/Region (2017-2022) & (Tons)
Table 30. Global Leflunomide Sales Market Share by Country/Region (2017-2022)
Table 31. Global Leflunomide Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Leflunomide Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Leflunomide Sales by Country (2017-2022) & (Tons)
Table 34. Americas Leflunomide Sales Market Share by Country (2017-2022)
Table 35. Americas Leflunomide Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Leflunomide Revenue Market Share by Country (2017-2022)
Table 37. Americas Leflunomide Sales by Type (2017-2022) & (Tons)
Table 38. Americas Leflunomide Sales Market Share by Type (2017-2022)
Table 39. Americas Leflunomide Sales by Application (2017-2022) & (Tons)
Table 40. Americas Leflunomide Sales Market Share by Application (2017-2022)
Table 41. APAC Leflunomide Sales by Region (2017-2022) & (Tons)
Table 42. APAC Leflunomide Sales Market Share by Region (2017-2022)
Table 43. APAC Leflunomide Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Leflunomide Revenue Market Share by Region (2017-2022)
Table 45. APAC Leflunomide Sales by Type (2017-2022) & (Tons)
Table 46. APAC Leflunomide Sales Market Share by Type (2017-2022)
Table 47. APAC Leflunomide Sales by Application (2017-2022) & (Tons)
Table 48. APAC Leflunomide Sales Market Share by Application (2017-2022)
Table 49. Europe Leflunomide Sales by Country (2017-2022) & (Tons)
Table 50. Europe Leflunomide Sales Market Share by Country (2017-2022)
Table 51. Europe Leflunomide Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Leflunomide Revenue Market Share by Country (2017-2022)
Table 53. Europe Leflunomide Sales by Type (2017-2022) & (Tons)
Table 54. Europe Leflunomide Sales Market Share by Type (2017-2022)
Table 55. Europe Leflunomide Sales by Application (2017-2022) & (Tons)
Table 56. Europe Leflunomide Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Leflunomide Sales by Country (2017-2022) & (Tons)
Table 58. Middle East & Africa Leflunomide Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Leflunomide Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Leflunomide Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Leflunomide Sales by Type (2017-2022) & (Tons)
Table 62. Middle East & Africa Leflunomide Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Leflunomide Sales by Application (2017-2022) & (Tons)
Table 64. Middle East & Africa Leflunomide Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Leflunomide
Table 66. Key Market Challenges & Risks of Leflunomide
Table 67. Key Industry Trends of Leflunomide
Table 68. Leflunomide Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Leflunomide Distributors List
Table 71. Leflunomide Customer List
Table 72. Global Leflunomide Sales Forecast by Region (2023-2028) & (Tons)
Table 73. Global Leflunomide Sales Market Forecast by Region
Table 74. Global Leflunomide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Leflunomide Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Leflunomide Sales Forecast by Country (2023-2028) & (Tons)
Table 77. Americas Leflunomide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Leflunomide Sales Forecast by Region (2023-2028) & (Tons)
Table 79. APAC Leflunomide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Leflunomide Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Europe Leflunomide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Leflunomide Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Middle East & Africa Leflunomide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Leflunomide Sales Forecast by Type (2023-2028) & (Tons)
Table 85. Global Leflunomide Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Leflunomide Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Leflunomide Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Leflunomide Sales Forecast by Application (2023-2028) & (Tons)
Table 89. Global Leflunomide Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Leflunomide Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Leflunomide Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Leflunomide Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Leflunomide Product Offered
Table 94. Sanofi Leflunomide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. DM Pharma Basic Information, Leflunomide Manufacturing Base, Sales Area and Its Competitors
Table 98. DM Pharma Leflunomide Product Offered
Table 99. DM Pharma Leflunomide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. DM Pharma Main Business
Table 101. DM Pharma Latest Developments
Table 102. Changzhou Yabang Pharmaceutical Basic Information, Leflunomide Manufacturing Base, Sales Area and Its Competitors
Table 103. Changzhou Yabang Pharmaceutical Leflunomide Product Offered
Table 104. Changzhou Yabang Pharmaceutical Leflunomide Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. Changzhou Yabang Pharmaceutical Main Business
Table 106. Changzhou Yabang Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Leflunomide
Figure 2. Leflunomide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Leflunomide Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Leflunomide Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Leflunomide Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 99% Purity
Figure 10. Product Picture of 99.5% Purity
Figure 11. Global Leflunomide Sales Market Share by Type in 2021
Figure 12. Global Leflunomide Revenue Market Share by Type (2017-2022)
Figure 13. Leflunomide Consumed in Rheumatoid Arthritis
Figure 14. Global Leflunomide Market: Rheumatoid Arthritis (2017-2022) & (Tons)
Figure 15. Leflunomide Consumed in Other
Figure 16. Global Leflunomide Market: Other (2017-2022) & (Tons)
Figure 17. Global Leflunomide Sales Market Share by Application (2017-2022)
Figure 18. Global Leflunomide Revenue Market Share by Application in 2021
Figure 19. Leflunomide Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Leflunomide Revenue Market Share by Company in 2021
Figure 21. Global Leflunomide Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Leflunomide Revenue Market Share by Geographic Region in 2021
Figure 23. Global Leflunomide Sales Market Share by Region (2017-2022)
Figure 24. Global Leflunomide Revenue Market Share by Country/Region in 2021
Figure 25. Americas Leflunomide Sales 2017-2022 (Tons)
Figure 26. Americas Leflunomide Revenue 2017-2022 ($ Millions)
Figure 27. APAC Leflunomide Sales 2017-2022 (Tons)
Figure 28. APAC Leflunomide Revenue 2017-2022 ($ Millions)
Figure 29. Europe Leflunomide Sales 2017-2022 (Tons)
Figure 30. Europe Leflunomide Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Leflunomide Sales 2017-2022 (Tons)
Figure 32. Middle East & Africa Leflunomide Revenue 2017-2022 ($ Millions)
Figure 33. Americas Leflunomide Sales Market Share by Country in 2021
Figure 34. Americas Leflunomide Revenue Market Share by Country in 2021
Figure 35. United States Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Leflunomide Sales Market Share by Region in 2021
Figure 40. APAC Leflunomide Revenue Market Share by Regions in 2021
Figure 41. China Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Leflunomide Sales Market Share by Country in 2021
Figure 48. Europe Leflunomide Revenue Market Share by Country in 2021
Figure 49. Germany Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Leflunomide Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Leflunomide Revenue Market Share by Country in 2021
Figure 56. Egypt Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Leflunomide Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Leflunomide in 2021
Figure 62. Manufacturing Process Analysis of Leflunomide
Figure 63. Industry Chain Structure of Leflunomide
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)